FI954141A - Oksatsolokinolonijohdannaiset, niiden valmistus ja niiden käyttö terapiassa - Google Patents

Oksatsolokinolonijohdannaiset, niiden valmistus ja niiden käyttö terapiassa Download PDF

Info

Publication number
FI954141A
FI954141A FI954141A FI954141A FI954141A FI 954141 A FI954141 A FI 954141A FI 954141 A FI954141 A FI 954141A FI 954141 A FI954141 A FI 954141A FI 954141 A FI954141 A FI 954141A
Authority
FI
Finland
Prior art keywords
therapy
preparation
oxazoloquinolinone
derivatives
oxazoloquinolinone derivatives
Prior art date
Application number
FI954141A
Other languages
English (en)
Swedish (sv)
Other versions
FI110945B (fi
FI954141A0 (fi
Inventor
Samir Jegham
Jean Jacques Koenig
Frederic Puech
Philippe Burnier
Lydia Zard
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of FI954141A0 publication Critical patent/FI954141A0/fi
Publication of FI954141A publication Critical patent/FI954141A/fi
Application granted granted Critical
Publication of FI110945B publication Critical patent/FI110945B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Quinoline Compounds (AREA)
FI954141A 1994-09-05 1995-09-04 Oksatsolokinolinonijohdannaisia, niiden valmistus ja niiden käyttö terapiassa FI110945B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9410600 1994-09-05
FR9410600A FR2724171B1 (fr) 1994-09-05 1994-09-05 Derives de 3,3a,4,5-tetrahydro-1h-oxazolo(3,4-a)quinolein-1-one, leur preparation et leur application en therapeutique

Publications (3)

Publication Number Publication Date
FI954141A0 FI954141A0 (fi) 1995-09-04
FI954141A true FI954141A (fi) 1996-03-06
FI110945B FI110945B (fi) 2003-04-30

Family

ID=9466686

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954141A FI110945B (fi) 1994-09-05 1995-09-04 Oksatsolokinolinonijohdannaisia, niiden valmistus ja niiden käyttö terapiassa

Country Status (28)

Country Link
US (1) US5641785A (fi)
EP (1) EP0699680B1 (fi)
JP (1) JP4225585B2 (fi)
KR (1) KR100392523B1 (fi)
CN (1) CN1055472C (fi)
AT (1) ATE190311T1 (fi)
AU (1) AU687591B2 (fi)
CA (1) CA2157427C (fi)
CZ (1) CZ286128B6 (fi)
DE (1) DE69515402T2 (fi)
DK (1) DK0699680T3 (fi)
ES (1) ES2145886T3 (fi)
FI (1) FI110945B (fi)
FR (1) FR2724171B1 (fi)
GR (1) GR3033554T3 (fi)
HK (1) HK1013652A1 (fi)
HU (1) HU218587B (fi)
IL (1) IL115276A (fi)
NO (1) NO306617B1 (fi)
NZ (1) NZ272920A (fi)
PL (1) PL184412B1 (fi)
PT (1) PT699680E (fi)
RU (1) RU2141482C1 (fi)
SI (1) SI0699680T1 (fi)
SK (1) SK281867B6 (fi)
TW (1) TW356467B (fi)
UA (1) UA41916C2 (fi)
ZA (1) ZA957414B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1078632A1 (en) * 1999-08-16 2001-02-28 Sanofi-Synthelabo Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity
WO2005090309A1 (en) * 2004-03-12 2005-09-29 Wyeth 1,2-dihydroquinoline derivatives and method for using the same to treat hiv infection
NZ579431A (en) * 2007-03-09 2012-04-27 Sanofi Aventis Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
RU2366430C2 (ru) 2007-05-23 2009-09-10 Виктор Иванович Рощин Ингибиторы моноаминооксидазы, лекарственное средство и фармацевтическая композиция
AR078171A1 (es) 2009-09-15 2011-10-19 Sanofi Aventis Dihidrobenzocicloalquiloximetil-oxazolopirimidinonas sustituidas, preparacion y uso de las mismas
CN105949120B (zh) * 2016-05-27 2018-07-24 广东工业大学 一种四齿螯合型单喹啉衍生物及其制备方法和作为神经退行性疾病的金属离子调节剂的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2624861B1 (fr) * 1987-12-21 1990-06-01 Delalande Sa Carbamates tricycliques, leur procede de preparation et leur application en therapeutique
ES2013391A6 (es) * 1989-02-08 1990-05-01 Consejo Superior Investigacion Procedimiento para la preparacion de derivados acetilenicos y alenicos de 2-aminometil -5-metoxiindoles.
JPH04295470A (ja) * 1991-03-22 1992-10-20 Wakamoto Pharmaceut Co Ltd モノアミンオキシダーゼ−ｂ酵素阻害活性を有する１，２，４−オキサジアゾール誘導体及びその製造法

Also Published As

Publication number Publication date
ZA957414B (en) 1996-04-15
NO953458L (no) 1996-03-06
SK108995A3 (en) 1996-06-05
ATE190311T1 (de) 2000-03-15
HK1013652A1 (en) 1999-09-03
HU9502578D0 (en) 1995-11-28
KR960010648A (ko) 1996-04-20
HUT73435A (en) 1996-07-29
IL115276A0 (en) 1996-01-19
NO306617B1 (no) 1999-11-29
CA2157427C (en) 2010-06-01
DE69515402T2 (de) 2000-10-19
US5641785A (en) 1997-06-24
SI0699680T1 (en) 2000-10-31
ES2145886T3 (es) 2000-07-16
KR100392523B1 (ko) 2003-11-12
CN1128763A (zh) 1996-08-14
EP0699680B1 (fr) 2000-03-08
CZ226295A3 (en) 1996-03-13
CZ286128B6 (cs) 2000-01-12
CN1055472C (zh) 2000-08-16
FR2724171A1 (fr) 1996-03-08
GR3033554T3 (en) 2000-09-29
AU3041595A (en) 1996-03-21
PT699680E (pt) 2000-08-31
HU218587B (hu) 2000-10-28
JP4225585B2 (ja) 2009-02-18
PL310273A1 (en) 1996-03-18
NO953458D0 (no) 1995-09-04
TW356467B (en) 1999-04-21
FR2724171B1 (fr) 1997-01-03
DK0699680T3 (da) 2000-08-21
FI110945B (fi) 2003-04-30
IL115276A (en) 1998-12-06
CA2157427A1 (en) 1996-03-06
SK281867B6 (sk) 2001-08-06
EP0699680A1 (fr) 1996-03-06
RU2141482C1 (ru) 1999-11-20
JPH0899881A (ja) 1996-04-16
NZ272920A (en) 1998-03-25
AU687591B2 (en) 1998-02-26
PL184412B1 (pl) 2002-10-31
UA41916C2 (uk) 2001-10-15
FI954141A0 (fi) 1995-09-04
DE69515402D1 (de) 2000-04-13

Similar Documents

Publication Publication Date Title
FI945703A (fi) 3,4,4-trisybstituoitujen piperidinyyli-N-alkyylikarboksylaattien ja välituotteiden valmistus
PT889886E (pt) Novas fenantridinas substituidas na posicao 6
DE69302508D1 (de) Taxanderivate, ihre Herstellung und ihre Anwendung in der Onkologie
FI914275A (fi) Bensimidazolderivat, framstaellning och anvaendning av dessa.
DE3879787D1 (de) 11beta-phenyl-4,9,15-estratriene, deren herstellung und diese enthaltende pharmazeutische praeparate.
FI925849A (fi) Tiazolidinfoereningar, deras framstaellning och terapeutiska anvaendningar
ES2112029T3 (es) Nuevos filtros solares, composiciones cosmeticas fotoprotectoras que los contienen y utilizaciones.
FI954141A0 (fi) Oksatsolokinolonijohdannaiset, niiden valmistus ja niiden käyttö terapiassa
ATE207887T1 (de) Neue n-aryl-2-hydroxy-alkylamide
FI913391A0 (fi) Foerfarande foer detektering av smaocellcarcinom och anvaendning av acylpeptidhydrolas och denna kodande sekvenser.
FI945427A (fi) Dynemisiinianalogien enantiomeerit, niiden valmistus ja käyttö
GR3033123T3 (en) Tricyclic derivatives, their preparation, their use in the preparation of optically active or racemic colchicine, thiocolchicine and analogues or derivatives, and intermediates
FI951323A (fi) Polyjodatut yhdisteet, menetelmä niiden valmistamiseksi ja diagnostiset koostumukset
FR2716198B1 (fr) Facteur cytotoxique tel qu'associé à la sclérose en plaques, sa détection et sa quantification.
FI952203A0 (fi) Sykloheksaanijohdannaiset, menetelmä niiden valmistamiseksi ja yhdisteiden käyttö sairauksien hoitamiseksi
FI20021652A (fi) Tratsodonin alkyylijohdannaisten valmistuksessa käyttökelpoisia välituotteita
FI912269A (fi) 3'-deamino - 4'deoxi - 4'-amino- 8 -fluorantracykliner och framstaellningsfoerfaranden foer dessa.
FR2688500B1 (fr) Composition de teinture des fibres keratiniques a base de 4-monoindolyl 1,2-naphtoquinones ou leurs leucoderives, nouveaux composes 4-monoindolyl 1,2-naphtoquinones et leurs leucoderives.
DE3865521D1 (de) 4-methyl-4-phenyl-1-pentanale, deren herstellung und verwendung als riechstoffe.
FI902272A0 (fi) Foerfarande foer isolering och vidarerening av plasmaproteinerna ttr och rbp.
SE8600411D0 (sv) Isokinolinderivat, deras framstellning och anvendning
ATE12645T1 (de) Phenylethylthiazolderivate, ihre herstellung und ihre anwendung in der therapeutik.

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: SANOFI-AVENTIS

MA Patent expired